Effect of Nutrition and Lifestyles on Obesity and Chronic Disease in China
NCT ID: NCT02509741
Last Updated: 2017-11-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
1000 participants
INTERVENTIONAL
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Educational intervention
High-protein and low-GI diet education
Education
Dietary intervention
High-protein and low-GI diet plus education
Education
Food replacement
Internet-of-things (IOT) monitoring intervention
Dietary intervention plus IOT monitoring
Education
Food replacement
IOT monitoring
control
Routine diet recommendation
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Education
Food replacement
IOT monitoring
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* The patients with chronic renal diseases or other diseases which impose restrictions on the intake of proteins.
* Mental patients.
* People who suffer from secondary obesity caused by endocrine, metabolic disorders or some central nervous system diseases.
* People who are under medical or surgical weight-loss treatments in the past three months.
* People whose weight fluctuations are not less than 5kg in the past two months；
* People with food allergies.
* Men or women who drink regularly over 25g or 15 g daily,respectively.
* Pregnant women and women who prepare to be pregnant.
* Lactating women
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese PLA General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Qiang Zeng
Director of Health Management Institue
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Qiang Zeng, MD
Role: PRINCIPAL_INVESTIGATOR
Chinese PLA General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Southwest Hospital
Chongqing, Chongqing Municipality, China
Hangzhou PLA sanatorium
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Xiaolan Zhao
Role: primary
Zili Zhong
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHPF2012014
Identifier Type: -
Identifier Source: org_study_id